The U.S. government has agreed to loan privately-held biotechnology firm Ginkgo Bioworks $1.1 billion for COVID-19 testing and the production of raw materials for therapies that may help address ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback